Minimally Invasive Surgery Market

Minimally Invasive Surgery Market by Product (Robotics, Imaging, Instrument (Handheld, inflation, Guiding, Electrosurgery, Endoscopy)), Application (CVD, Thoracic, Neuro, ENT, OB/GYN, Orthopedic), End User & Region - Global Forecast to 2029

Report Code: MD 1250 Mar, 2024, by marketsandmarkets.com

The global minimally invasive surgery market is projected to reach USD 74.6 billion by 2029 from USD 34.0 billion in 2024, growing at a CAGR of 17.0% during the forecast period.The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.

An increase in chronic disorders and the aging population, increasing research & funding initiatives from organizations, and worldwide advancement in surgical procedures are a few drivers that collectively contribute to the growth of the minimally invasive surgery market, and as healthcare technologies continue to evolve, the demand for minimally invasive surgical procedure is expected to rise further in the upcoming years. However, challenges for high cost, regulatory issues can limits the market growth.

Attractive Opportunities in the Minimally Invasive Surgery Market

Minimally Invasive Surgery Market

To know about the assumptions considered for the study, Request for Free Sample Report

Minimally Invasive Surgery Market

Minimally Invasive Surgery Market: Market Dynamics

Driver: Increase adoption of MIS over open surgeries

Laparoscopic procedures are less invasive and save costs in terms of pre- and post-operation care and the length of stay in hospitals. These surgeries result in less blood loss, fewer postoperative complications, and a shorter recovery time for patients. In addition, minimally invasive surgeries are increasingly being covered by health insurance providers in select countries. Physicians prefer minimally invasive surgeries over traditional open surgeries as they consider it to be a cost-saving opportunity for hospitals.

Restraint: High cost of Robotic systems

Robot-assisted surgeries are much more expensive than minimally invasive surgeries. This often results in deferred or altogether avoided treatments. The high cost of robotic surgery is further increased by the fact that the annual maintenance cost of robots is around USD 125,000. Hospital budget cuts were similar throughout European countries, and more cuts are anticipated in the upcoming years. Budget cuts have made cost-containment measures necessary in many areas of hospital operations.

Opportunity: Emerging markets- growth opportunities

Emerging markets are evolving into growth areas for the minimally invasive surgery. A myriad of factors contribute to the growth opportunities within these markets, attributed to their low regulatory barriers, improvements in healthcare infrastructure, growing patient population, and rising healthcare expenditure, escalating disposable incomes, and a burgeoning aging demographic. Asia Pacific region are more adaptive and business-friendly than those in developed countries. This, along with the increasing competition in mature markets, has drawn top players in the minimally invasive surgery market to focus on emerging countries.

Challenge: High degree of market consolidaton

The minimally invasive surgery market is highly consolidated. Only key companies are able to afford high capital invaestments as well as the high cost of research & development and manufacturing. It will prevent new entrant to enter the minimally invasive surgery market. Top player salso enjoys the high degree of brand loyalty. Whereas new entrant have to compete with existing key players to offer and set themselves by developing innovative product offerings.

Minimally Invasive Surgery Industry Ecosystem

Major companies in this market include well-established and financially stable suppliers of minimally invasive surgery. Prominent companies in this market include Medtronic plc (Ireland), Johnson & Johnson (US), Stryker corporation (US), NuVasive (US), Abbott Laboratories (US), Zimmer Biomet holdings (Warsaw), Boston Scientific Corporation (US), GE Healthcare (US) among several others.

Minimally Invasive Surgery Market Ecosystem

Surgical devices segment to register largest market share of the minimally invasive surgery industry in the year 2023.

Based on the product, the minimally invasive surgery market is segmented into Surgical Devices, Imaging & Visualization Systems, Endoscopy Devices, Electrosurgical Devices, and Medical Robotics. Surgical Devices segment to register largest market share in the forecast period of 2023-2029. The surgical devices further divided into Handheld instruments, laparoscopy devices, guiding devices and inflation system. Key drivers fostering the expansion of minimally invasive surgery (MIS) via surgical devices encompass ongoing technological advancements, which continuously elevate the precision, adaptability, and safety of these instruments. Furthermore, the market's growth is further bolstered by the introduction of advance surgical technologies by key industry players.

Neurological Surgery segment is the highest market rate application segment in the minimally invasive surgery industry forecasted year 2023-2029.

The Neurological surgery application segment register highest market rate in the forecasted year 2023-2029 . Key factors propelling the adoption of minimally invasive surgery (MIS) in neurological procedures include advancements in technology, particularly in imaging modalities and surgical instrumentation, which enable more precise and minimally invasive interventions. Additionally, the imperative to minimize patient morbidity, lower post-operative complications, and accelerate recovery periods serves as a significant impetus for the adoption of MIS in neurological surgery. Furthermore, evolving healthcare paradigms prioritizing value-based care and patient-centric outcomes further propel the integration of MIS in neurological surgery.

Asia-Pacific is expected to be the highest CAGR of the minimally invasive surgery industry during the forecast period.

The minimally invasive surgery market is divided into key regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2023, North America held the largest market share in the global minimally invasive surgery market. However, the Asia Pacific region is anticipated to exhibit the highest CAGR during the forecast period. This growth is primarily attributed to the a rise in healthcare budgets, demographic shift with a rapidly aging population,and investing in healthcare infrastructure. Patients increasingly seek minimally invasive alternatives to traditional surgery due to the perceived benefits, such as shorter hospital stays, reduced pain, and quicker recovery. As patient awareness and demand for MIS options rise, healthcare providers are more likely to offer and promote these procedures. This includes advancements in surgical techniques and the adoption of advanced minimally invasive surgery. Additionally, the market in the Asia Pacific region is set to receive a boost from the growing number of local manufacturers offering minimally invasive surgery products.

Minimally Invasive Surgery Market by Region

To know about the assumptions considered for the study, download the pdf brochure

As of 2022, prominent players in the market are Medtronic plc (Ireland), Johnson & Johnson Medtech (US), Stryker corporation (US), NuVasive (US), GE Healthcare (US), Zimmer Biomet holdings (Warsaw), Becton, Dickinson & Company. (US), Boston Scientific Corporation (US), Abbott Laboratories (US) among several others.

Scope of the Minimally Invasive Surgery Industry

Report Metric

Details

Market Revenue in 2024

$34.0 billion

Projected Revenue by 2029

$74.6 billion

Revenue Rate

Poised to Grow at a CAGR of 17.0%

Market Driver

Increase adoption of MIS over open surgeries

Market Opportunity

Emerging markets- growth opportunities

This report has segmented the minimally invasive surgery market to forecast revenue and analyze trends in each of the following submarkets:

By Product (USD Million; 2021—2029) *

  • Surgical Devices
    • Handheld Instruments
      • Tubular Retractor
      • Dilator
      • Suturing Instruments
        • Probes
        • Laser fiber devices
    • Guiding Devices
      • Guiding catheters
      • Guidewires
    • Inflation Systems
      • Balloon Catheters
      • Balloon inflation system
    • Laparoscopy Devices
      • Laparoscope
      • Trocar and Cannula
      • RASP (Robotic- Assisted Simple Prostatectomy)
      • Graspers and Dissectors
  • Imaging & Visualization Systems
    • Ultrasound
    • CT imaging
    • MRI imaging
    • X-Ray imaging
    • Visualization systems
  • Electrosurgical Devices
    • Electrosurgical generators & accessories
    • Electrocautery devices
  • Endoscopy Devices
    • Rigid endoscopes
    • Flexible endoscopes
    • Diagnostic endoscopes
  • Medical Robotics
    • Robotic Systems
    • Robotic Instruments
    • Robotic softwares & Services

By Application (USD Million; 2021—2029) *

  • Cardio-Thoracic Surgery
  • Vascular Surgery
  • Neurological Surgery
  • Ent & Respiratory Surgery
  • Cosmetic Surgery
  • Gastrointestinal & Abdominal Surgery
  • Gynecological Surgery
  • Urological Surgery
  • Orthopedic Surgery
  • Oncology Surgery
  • Dental Surgery
  • Others

By End User (USD Million; 2021—2029) *

  • Hospitals, Clinics & Ablation centers
  • Ambulatory Surgical Centers
  • Orthopedic, Emergency & Trauma Centers
  • Others

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
  • MEA

Recent Market Developments of Minimally Invasive Surgery Industry:

  • In 2023, Medtronic receives CE Mark approval for Affera Mapping and Ablation System to treat atrial arrhythmias.
  • In 2023, J&J MONARCH Platform is the first minimally invasive, robotic-assisted technology approved for bronchoscopy in China with significant burden of lung cancer.
  • In 2023, Stryker’s Q Guidance System for cranial applications received US FDA clearance to support cranial surgeries.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION 
    1.1 OBJECTIVES OF THE STUDY  
    1.2 MARKET DEFINITION  
           1.2.1 KEY INCLUSIONS & EXCLUSIONS 
    1.3 RESEARCH SCOPE  
           1.3.1 SEGMENTS COVERED 
           1.3.2 GEOGRAPHIC SCOPE 
           1.3.3 YEARS CONSIDERED FOR THE STUDY 
    1.4 CURRENCY USED FOR THE STUDY  
    1.5 MAJOR MARKET STAKEHOLDERS  
    1.6 SUMMARY OF CHANGES  
           1.6.1 RECESSION IMPACT 
 
2 RESEARCH METHODOLOGY  
    2.1 RESEARCH DATA SOURCES 
           2.1.1 SECONDARY DATA 
           2.1.2 PRIMARY DATA
    2.2 MARKET SIZE ESTIMATION METHODOLOGY  
    2.3 MARKET SHARE ESTIMATION METHODOLOGY  
    2.4 MARKET BREAK DOWN AND DATA TRIANGULATION  
    2.5 RESEARCH ASSUMPTIONS 
    2.6 RESEARCH LIMITATIONS  
           2.6.1 SCOPE RELATED LIMITATIONS 
           2.6.2 METHODOLOGY RELATED LIMITATIONS
    2.7 RISK ASSESSMENT  
    2.8 RECESSION IMPACT ASSESSMENT APPROACH  
 
3 EXECUTIVE SUMMARY  
 
4 PREMIUM INSIGHTS  
 
5 MARKET OVERVIEW  
    5.1 MARKET DYNAMICS  
           5.1.1 MAJOR DRIVERS 
           5.1.2 KEY RESTRAINTS
           5.1.3 KEY GROWTH OPPORTUNITIES 
           5.1.4 INDUSTRY-SPECIFIC CHALLENGES 
 
    5.2 TARIFF AND REGULATORY LANDSCAPE 
           5.2.1 TARIFF RELATED TO MINIMALLY INVASIVE MEDICAL ROBOTICS, IMAGING VISUALISATION SYSTEMS & SURGICAL INSTRUMENTS
           5.2.2 REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS
           5.2.3 REGULATORY TRENDS, BY REGION
    5.3 VALUE CHAIN ANALYSIS 
    5.4 SUPPLY CHAIN ANALYSIS 
    5.5 ECOSYSTEM ANALYSIS 
    5.6 TECHNOLOGY ANALYSIS 
           5.6.1 KEY TECHNOLOGIES
                    5.6.1.1  LAPAROSCOPY
                    5.6.1.2  ABLATION 
                    5.6.1.3  ELECTROSURGERY
                    5.6.1.2  POWERED SURGICAL PRODUCT 
           5.6.2 COMPLEMENTARY TECHNOLOGIES
                    5.6.2.1  ROBOTIC SURGERY
                    5.6.2.2  DIGITAL SOLUTION (AI, IOT)
                    5.6.2.3  MEDICAL/ SURGICAL IMAGING
           5.6.3 ADJECENT TECHNOLOGIES
                    5.6.3.1  ENDOSCOPE
                    5.6.3.2  SURGICAL IMPLANTS
    5.7 REIMBURSEMENT SCENARIO 
    5.8 INVESTMENT AND FUNDING SCENARIO 
    5.9 TRADE DATA 
    5.10 PATENT DATA  
    5.11 PORTER’S FIVE FORCE ANALYSIS 
    5.12 PRICING ANALYSIS 
           5.12.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT
           5.12.2 AVERAGE SELLING PRICE TREND, BY REGION
    5.13 CASE STUDY ANALYSIS 
    5.14 KEY CONFERENCES AND EVENTS IN 2024-25 
    5.15 KEY STAKEHOLDERS & BUYING CRITERIA 
           5.15.1 KEY STAKEHOLDERS IN THE BUYING PROCESS
           5.15.2 BUYING CRITERIA
    5.16 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 
    5.17 CUSTOMER UNMET NEEDS IN MINIMALLY INVASIVE MEDICAL ROBOTICS, IMAGING VISUALISATION SYSTEMS & SURGICAL INSTRUMENTS MARKET 
 
6 MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT (USD MILLION; 2021—2029) *  
    6.1 SURGICAL DEVICES 
           6.1.1 HANDHELD INSTRUMENTS
                    6.1.1.1 Tubular Retractor
                    6.1.1.2 Dilator
                    6.1.1.3 Suturing Instruments
                    6.1.1.4 Probes
                    6.1.1.5 Laser fiber devices
           6.1.2 GUIDING DEVICES
                    6.1.2.1 Guiding catheters
                    6.1.2.2 Guidewires
           6.1.3 INFLATION SYSTEMS
                    6.1.3.1 Balloon Catheters
                    6.1.3.2 Balloon inflation system
           6.1.4 LAPAROSCOPY DEVICES
                    6.1.4.1 Laparoscope
                    6.1.4.2 Trocar and Cannula
                    6.1.4.3 RASP (Robotic- Assisted Simple Prostatectomy)
                    6.1.4.4 Graspers and Dissectors
    6.2 IMAGING & VISUALIZATION SYSTEMS 
           6.2.1 ULTRASOUND
           6.2.2 CT IMAGING
           6.2.3 MRI IMAGING
           6.2.4 X-RAY IMAGING
           6.2.5 VISUALIZATION SYSTEMS
    6.3 ELECTROSURGICAL DEVICES 
           6.3.1 ELECTROSURGICAL GENERATORS & ACCESSORIES
           6.3.2 ELECTROCAUTERY DEVICES
    6.4 ENDOSCOPY DEVICES 
           6.4.1 RIGID ENDOSCOPES
           6.4.2 FLEXIBLE ENDOSCOPES
           6.4.3 DIAGNOSTIC ENDOSCOPES
    6.5 MEDICAL ROBOTICS 
           6.5.1 ROBOTIC SYSTEMS
           6.5.2 ROBOTIC INSTRUMENTS
           6.5.4 ROBOTIC SOFTWARES & SERVICES
 
7 MINIMALLY INVASIVE SUREGRY MARKET, BY APPLICATION (USD MILLION; 2021—2029) * 
    7.1 CARDIO-THORACIC SURGERY 
    7.2 VASCULAR SURGERY 
    7.3 NEUROLOGICAL SURGERY 
    7.4 ENT & RESPIRATORY SURGERY 
    7.5 COSMETIC SURGERY 
    7.6 GASTROINTESTINAL & ABDOMINAL SURGERY 
    7.7 GYNECOLOGICAL SURGERY 
    7.8 UROLOGICAL SURGERY 
    7.9 ORTHOPEDIC SURGERY 
    7.10 ONCOLOGY SURGERY 
    7.11 DENTAL SURGERY 
    7.12 OTHERS 
 
8 MINIMALLY INVASIVE SURGERY MARKET, BY END USER (USD MILLION; 2021—2029) *  
    8.1 HOSPITALS, CLINICS & ABLATION CENTERS 
    8.2 AMBULATORY SURGICAL CENTERS 
    8.3 ORTHOPEDIC, EMERGENCY & TRAUMA CENTERS 
    8.3 OTHERS 
 
9 MINIMALLY INVASIVE SURGERY MARKET, BY REGION (USD MILLION; 2021—2029)* 
    9.1 NORTH AMERICA 
           9.1.1 RECESSION IMPACT
           9.1.2 US
           9.1.3 CANADA 
    9.2 EUROPE  
           9.2.1 RECESSION IMPACT
           9.2.2 GERMANY
           9.2.3 UK
           9.2.4 FRANCE
           9.2.5 ITALY 
           9.2.6 SPAIN 
           9.2.7 REST OF EUROPE
    9.3 ASIA-PACIFIC 
           9.3.1 RECESSION IMPACT
           9.3.2 JAPAN 
           9.3.3 CHINA 
           9.3.4 INDIA 
           9.3.5 SOUTH KOREA 
           9.3.6 AUSTRALIA 
           9.3.7 REST OF ASIA-PACIFIC
    9.4 LATIN AMERICA 
           9.4.1 RECESSION IMPACT
           9.4.2 BRAZIL
           9.4.3 MEXICO
           9.4.4 REST OF LATIN AMERICA 
    9.5 MIDDLE EAST AND AFRICA  
           9.5.1 RECESSION IMPACT
           9.4.3 GCC COUNTRIES
 
10 COMPETITIVE LANDSCAPE  
     10.1 OVERVIEW  
     10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 
     10.3 REVENUE ANALYSIS OF KEY PLAYERS (2023)  
     10.4 MARKET SHARE ANALYSIS FOR TOP 5 GLOBAL PLAYERS (IN TERMS OF %REVENUE, IN 2022)  
             10.4.1 MINIMALLY INVASIVE MEDICAL ROBOTICS 
             10.4.2 IMAGING VISUALISATION SYSTEMS
             10.4.3 SURGICAL INSTRUMENTS
             10.4.4 ELECTROSURGICAL DEVICES
             10.4.5 ENDOSCOPY DEVICES
 
     10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 
             10.5.1 STARS 
             10.5.2 EMERGING LEADERS
             10.5.3 PERVASIVE PLAYERS
             10.5.4 PARTICIPANTS
             10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
                        10.5.5.1 COMPANY FOOTPRINT
                        10.5.5.2 REGION FOOTPRINT 
                        10.5.5.3 PRODUCT FOOTPRINT
                        10.5.5.4 APPLICATION FOOTPRINT 
                        10.5.5.5 END-USER FOOTPRINT
     10.6 COMPANY EVALUATION MATRIX: STARTUPS/ SMES, 2023 
             10.6.1 PROGRESSIVE COMPANIES
             10.6.2 RESPONSIVE COMPANIES
             10.6.3 DYNAMIC COMPANIES
             10.6.4 STARTING BLOCKS
             10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
                        10.6.5.1 DETAILED LIST OF KEY STARTUPS/SMES
                        10.6.5.2 COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 
     10.7 COMPETITIVE SCENARIO AND TRENDS (2021-2023)  
             10.7.1 PRODUCT LAUNCHES
             10.7.2 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
             10.7.3 MERGERS & ACQUISITIONS
             10.7.4 EXPANSIONS
     10.8 PRODUCT COMPARISON  
     10.9 COMPANY VALUATION AND FINANCIAL METRICS  
 
11 COMPANY PROFILES** 
(Business Overview, Products Offered, Industry-specific Developments for 2021-2023)***
     11.1 KEY COMPANIES  
             11.1.1 MEDTRONIC, PLC
             11.1.2 JOHNSONS & JOHNSONS
             11.1.3 ABBOTT LABORATORIES
             11.1.4 STRYKER CORPORATION
             11.1.5 BECTON, DICKINSON AND COMPANY
             11.1.6 SIEMENS HEALTHINEERS
             11.1.7 SMITH & NEPHEW
             11.1.8 PHILIPS HEALTHCARE
             11.1.9 FUJIFILM CORPORATION
             11.1.10 COOPERSURGICAL INC.
             11.1.11 GE HEALTHCARE
             11.1.12 BOSTON SCIENTIFIC
             11.1.13 ABBOTT LABORATORIES
             11.1.14 TELEFLEX
             11.1.15 B. BRAUN MELSUNGEN
     11.2 OTHER PLAYERS  
             11.2.1 COOK MEDICAL
             11.2.2 ZIMMER BIOMET HOLDINGS
             11.2.3 OLYMPUS CORPORATION
             11.2.4 INTUITIVE SURGICAL INC.
             11.2.5 KARL STORZ
             11.2.6 EDWARDS LIFESCIENCES CORP
             11.2.7 NIPRO CORPORATION
             11.2.8 GETINGE AB
             11.2.9 INTEGRA LIFESCIENCES
             11.2.10 NUVASIVE INC.
             11.2.11 CONMED CORPORATION 
             11.2.12 APPLIED MEDICAL
             11.2.13 ACCURAY
             11.2.14 RICHARD WOLF
             11.2.15 ATEC SPINE, INC.
 
12 APPENDIX 

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the minimally invasive surgery market. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in product therapy markets. The primary sources from the demand side include medical OEMs, Analytical instrument OEMs, CDMOs, and service providers, among others. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.

A breakdown of the primary respondents is provided below:

Minimally Invasive Surgery Market Size, and Share

*Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

Note: Companies are classified into tiers based on their total revenue. As of 2021, Tier 1 = >USD 2 billion, Tier 2 = USD 50 million to USD 2 billion, and Tier 3 = <USD 50 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Estimation Methodology

In this report, the minimally invasive surgery market size was determined using the revenue share analysis of leading players. For this purpose, key players in the market were identified, and their revenues from the minimally invasive surgery market business were determined through various insights gathered during the primary and secondary research phases. Secondary research included the study of the annual and financial reports of the top market players. In contrast, primary research included extensive interviews with key opinion leaders, such as CEOs, directors, and key marketing executives.

To calculate the global market value, segmental revenues were calculated based on the revenue mapping of major solution/service providers. This process involved the following steps:

  • Generating a list of major global players operating in the minimally invasive surgery market.
  • Mapping annual revenues generated by major global players from the minimally invasive surgery market(or nearest reported business unit/product category)
  • Revenue mapping of key  players to cover a major share of the global market, as of 2022
  • Extrapolating the global value of the minimally invasive surgery market

Global Minimally Invasive Surgery Market: Bottom-Up Approach

Minimally Invasive Surgery Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Global Minimally Invasive Surgery: Top-Down Approach

Minimally Invasive Surgery Market Size, and Share

Minimally Invasive Surgery Market Size, and Share

Data Triangulation

After arriving at the overall market size from the market size estimation process explained above, the minimally invasive surgery market was split into segments and subsegments. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides. Additionally, the minimally invasive surgery market was  validated using both top-down and bottom-up approaches.

Market Definition

Minimally invasive surgery (MIS) is a surgical procedure done in a manner that causes little to no trauma or injury to a patient. MIS is executed through a cannula using lasers, endoscopes or laparoscopes. MIS involves less bleeding, smaller amounts of anesthesia, less pain, and minimal scarring than other procedures. The surgical instruments used to make minute incisions in the body and perform MIS procedures are minimally invasive.

Key Stakeholders

  • Manufacturers and distributors of minimally invasive surgical instruments
  • Hospitals and clinics
  • Ambulatory surgical centers
  • Research and development (R&D) companies
  • Clinical research organizations
  • Research laboratories and academic institutes
  • Minimally invasive surgical instruments service providers
  • Government associations
  • Venture capitalists and investors

Objectives of the Study

  • To define, describe, and forecast the minimally invasive surgery market on Product, application and end user.
  • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze the micro markets concerning individual growth trends, prospects,  and contributions to the total market.
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders.
  • To profile the key market players and comprehensively analyze their market shares and core competencies.
  • To forecast the revenue of the market segments concerning five main regions, namely, North America (US and Canada), Europe (Germany, France, the UK, Italy, Spain, and Rest of Europe), the Asia Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and the Middle East & Africa.
  • To track and analyze competitive developments such as new product launches and approvals; agreements, partnerships, expansions, acquisitions; and collaborations in the minimally invasive surgery market.

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the present global minimally invasive surgery market

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of the top thirteen companies.

Company Information

  • Detailed analysis and profiling of additional market players (up to 15)

Geographic Analysis

  • Further breakdown of the Rest of Europe's minimally invasive surgery market Russia, Belgium, the Netherlands, Switzerland, Austria, Finland, Sweden, Poland, and Portugal among other
  • Further breakdown of the Rest of Asia Pacific minimally invasive surgery market Singapore, Taiwan, New Zealand, Philippines, Malaysia, and other APAC countries
  • Further breakdown of the Rest of the world minimally invasive surgery market Latin America, MEA, and Africa
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
MD 1250
Published ON
Mar, 2024
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Minimally Invasive Surgery Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback